⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Jasper Therapeutics, Inc. Common Stock

$13.37
-1.39 (-9.42%)

Volume:

29.595K ($397.14K)

Market Capitalization:

$14.84M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Jasper Therapeutics Market Segments

After Hours

+0.00(+0.00%)
Open$13.37
Close$13.37
Low$13.37
Low Change0.00 (0.00%)
High$13.37
High Change+0.00 (+0.00%)
Range$0.00
Volume484
Dollar Volume$6.47K

Regular Trading Hours

-0.85(-5.96%)
Open$14.27
Close$13.42
Low$13.40
Low Change-0.88 (-6.13%)
High$14.99
High Change+0.72 (+5.05%)
Range$1.60
Volume29.111K
Dollar Volume$390.67K

Premarket

*No Trades in Segment

Overnight

*No Trades in Segment

After Hours Yesterday

-0.26(-1.76%)
Open$14.76
Close$14.50
Low$13.76
Low Change-1.00 (-6.78%)
High$14.76
High Change+0.00 (+0.00%)
Range$1.00
Volume1.951K
Dollar Volume$28.29K

Regular Trading Hours Yesterday

-0.28(-1.86%)
Open$15.04
Close$14.76
Low$13.64
Low Change-1.40 (-9.31%)
High$15.45
High Change+0.41 (+2.73%)
Range$1.81
Volume63.366K
Dollar Volume$935.28K

Premarket Yesterday

*No Trades in Segment

Jasper Therapeutics Top Trades

Jasper Therapeutics's top trade so far today returned +5.05%, while the top short trade returned -10.81%.

Jasper Therapeutics Moving Averages

5 Day Moving Average (SMA5)$12.66
10 Day Moving Average (SMA10)$6.58
20 Day Moving Average (SMA20)$3.55
50 Day Moving Average (SMA50)$1.78
100 Day Moving Average (SMA100)$1.22
200 Day Moving Average (SMA200)$1.11

Jasper Therapeutics Statistics

Average Volume (30 Days)379.82K
P/E Ratio (Current)-.52
EPS (Current)-$28.62
Dividend Yield0.00%
Free Cash Flow-$60.33M
Cash Ratio0.93
Current Ratio1.47
Quick Ratio1.47
Debt to Equity0.00
Enterprise Value$9.06M
EV to EBITDA-0.17
EV to Sales—
Price to Book11.59
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-2.69%
Return on Equity-22.48%

Jasper Therapeutics Stock Splits

There have been 2 stock splits for Jasper Therapeutics (JSPR). The last reverse stock split occured on November 6, 2026 and reduced the outstanding shares at a ratio of 30:1.

DateTypeRatio
Nov 6, 2026Reverse30:1
Jan 4, 2024Reverse10:1

Jasper Therapeutics Dividends

There have been no dividends for Jasper Therapeutics (JSPR).